Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Relating Genomic Aberrations in Prostate Cancer to Tumour Hypoxia and Response to Treatment
FY 2015-16
Summary
The major goal of the Boutros lab is to personalize cancer medicine by applying computational models to big data.Each year, ~900,000 men around the word are diagnosed with prostate cancer and ~250,000 die from the disease. Localized cases are classified as low-risk, intermediate-risk or high-risk using clinical measurements to help guide treatment decisions. However, these groupings are imprecise: for example 30-50% of intermediate-risk patients suffer relapse of their disease after radiotherapy. One reason for differing response to treatment is the cellular and molecular heterogeneity of tumours (not all tumours are the same). Tumour cells also exist within an environment that has gradients of low oxygen levels (hypoxia). Patients with hypoxic tumours can rapidly fail treatment.Previous work in the Boutros lab created a signature that predicts patient survival using genomic and hypoxia data. This signature outperformed many previously reported signatures, showing the value of integrating genomic and hypoxia data.My goal is to further link tumour genomics, microenvironment and response to treatment. To do so, I will look at 139 tumours that have been thoroughly characterized (whole-genome sequencing, RNA-sequencing and methylation profiling). Tumour hypoxia measurements are also available for all tumours. I will analyze these data to relate genomic information to hypoxia. I will also use machine-learning to link these criteria to patient survival. With the computational facilities at the Ontario Institute for Cancer Research, the Boutros group is well equipped to do this work. Better understanding this relationship is critical to improving the lives of the ~25,000 Canadian men diagnosed with prostate cancer each year.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
350044
Name
Bhandari Vinayak
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Relating Genomic Aberrations in Prostate Cancer to Tumour Hypoxia and Response to Treatment
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Big Data; Bioinformatics; Hypoxia; Machine Learning; Personalized Medicine; Prostate Cancer; Rna Sequencing; Tumour Heterogeneity; Tumour Microenvironment; Whole-Genome Sequencing
Abstract
The major goal of the Boutros lab is to personalize cancer medicine by applying computational models to big data.Each year, ~900,000 men around the word are diagnosed with prostate cancer and ~250,000 die from the disease. Localized cases are classified as low-risk, intermediate-risk or high-risk using clinical measurements to help guide treatment decisions. However, these groupings are imprecise: for example 30-50% of intermediate-risk patients suffer relapse of their disease after radiotherapy. One reason for differing response to treatment is the cellular and molecular heterogeneity of tumours (not all tumours are the same). Tumour cells also exist within an environment that has gradients of low oxygen levels (hypoxia). Patients with hypoxic tumours can rapidly fail treatment.Previous work in the Boutros lab created a signature that predicts patient survival using genomic and hypoxia data. This signature outperformed many previously reported signatures, showing the value of integrating genomic and hypoxia data.My goal is to further link tumour genomics, microenvironment and response to treatment. To do so, I will look at 139 tumours that have been thoroughly characterized (whole-genome sequencing, RNA-sequencing and methylation profiling). Tumour hypoxia measurements are also available for all tumours. I will analyze these data to relate genomic information to hypoxia. I will also use machine-learning to link these criteria to patient survival. With the computational facilities at the Ontario Institute for Cancer Research, the Boutros group is well equipped to do this work. Better understanding this relationship is critical to improving the lives of the ~25,000 Canadian men diagnosed with prostate cancer each year.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bhandari, Vinayak
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~